Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced pemphigus

D F Mutasim1, N J Pelc, G J Anhalt

  • 1Department of Dermatology, University of Cincinnati Medical Center, Ohio.

Dermatologic Clinics
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased recognition of paraneoplastic pemphigus in patients previously treated with anti-CD 20 monoclonal antibodies.

The British journal of dermatology·2019
Same author

Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.

Clinical and experimental immunology·2010
Same author

Successful treatment of disseminated granuloma annulare with methotrexate.

The British journal of dermatology·2010
Same author

Lupus erythematosus tumidus as a separate subtype of cutaneous lupus erythematosus.

The British journal of dermatology·2010
Same author

Treatment of pyoderma gangrenosum with intravenous immunoglobulin.

The British journal of dermatology·2007
Same author

Visualization of hemodynamics in a silicon aneurysm model using time-resolved, 3D, phase-contrast MRI.

AJNR. American journal of neuroradiology·2006
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Drug-induced pemphigus involves medications triggering acantholysis, often mimicking idiopathic pemphigus. Some cases lack autoimmune markers and resolve upon drug cessation.

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Drug-induced pemphigus is a condition where medications cause acantholysis, a separation of skin cells.
  • It presents heterogeneously, with most patients exhibiting autoimmune features similar to idiopathic pemphigus.

Purpose of the Study:

  • To summarize the characteristics of drug-induced pemphigus.
  • To differentiate between autoimmune and non-autoimmune presentations.

Main Methods:

  • Literature review of drug-induced pemphigus cases.
  • Analysis of clinical and immunological features.

Main Results:

  • Most patients with drug-induced pemphigus show immune markers and a clinical course akin to idiopathic pemphigus.
  • A subset of patients lacks detectable autoimmune processes, with eruptions resolving after drug withdrawal.

Related Experiment Videos

Conclusions:

  • Drug-induced pemphigus is a diverse condition with varied underlying mechanisms.
  • Understanding these differences is crucial for patient management and treatment strategies.